View in EDS HTML Full Text PDF Full Text

Switching to subcutaneous zilucoplan from intravenous complement component 5 inhibitors in generalised myasthenia gravis: a phase IIIb, open-label study.

Saved in:
Bibliographic Details
Title: Switching to subcutaneous zilucoplan from intravenous complement component 5 inhibitors in generalised myasthenia gravis: a phase IIIb, open-label study.
Authors: Freimer M; Department of Neurology, The Ohio State University Wexner Medical Center, 395 West 12th Avenue, 7th Floor, Columbus, OH 43210, USA., Desai U; Atrium Health, Wake Forest University, Charlotte, NC, USA., Govindarajan R; HSHS St. Elizabeth's Hospital, O'Fallon, IL, USA., Kang MK; Department of Neurology, University of California San Francisco, San Francisco, CA, USA., Khan S; Department of Neurology, UT Southwestern Medical Center, Dallas, TX, USA., Khatri B; The Regional MS Center and Center for Neurological Disorders, Milwaukee, WI, USA., Levine T; HonorHealth Neurology, Bob Bové Neuroscience Institute, Scottsdale, AZ, USA., Macwan S; Department of Neurology, Eisenhower Health, Rancho Mirage, CA, USA., Shieh PB; Department of Neurology and Pediatrics, University of California Los Angeles, Los Angeles, CA, USA., Weiss MD; Department of Neurology, University of Washington Medical Center, Seattle, WA, USA., Bloemers J; UCB, Brussels, Belgium., Boroojerdi B; UCB, Monheim, Germany., Delicha EM; UCB, Braine-l'Alleud, Belgium., Lavrov A; UCB, Monheim, Germany., Singh P; UCB, Slough, UK., Howard JF Jr; Department of Neurology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Source: Therapeutic advances in neurological disorders [Ther Adv Neurol Disord] 2025 Jul 05; Vol. 18, pp. 17562864251347283. Date of Electronic Publication: 2025 Jul 05 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: SAGE Country of Publication: England NLM ID: 101480242 Publication Model: eCollection Cited Medium: Print ISSN: 1756-2856 (Print) Linking ISSN: 17562856 NLM ISO Abbreviation: Ther Adv Neurol Disord Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40620733
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Switching to subcutaneous zilucoplan from intravenous complement component 5 inhibitors in generalised myasthenia gravis: a phase IIIb, open-label study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Freimer+M%22">Freimer M</searchLink>; Department of Neurology, The Ohio State University Wexner Medical Center, 395 West 12th Avenue, 7th Floor, Columbus, OH 43210, USA.<br /><searchLink fieldCode="AU" term="%22Desai+U%22">Desai U</searchLink>; Atrium Health, Wake Forest University, Charlotte, NC, USA.<br /><searchLink fieldCode="AU" term="%22Govindarajan+R%22">Govindarajan R</searchLink>; HSHS St. Elizabeth's Hospital, O'Fallon, IL, USA.<br /><searchLink fieldCode="AU" term="%22Kang+MK%22">Kang MK</searchLink>; Department of Neurology, University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Khan+S%22">Khan S</searchLink>; Department of Neurology, UT Southwestern Medical Center, Dallas, TX, USA.<br /><searchLink fieldCode="AU" term="%22Khatri+B%22">Khatri B</searchLink>; The Regional MS Center and Center for Neurological Disorders, Milwaukee, WI, USA.<br /><searchLink fieldCode="AU" term="%22Levine+T%22">Levine T</searchLink>; HonorHealth Neurology, Bob Bové Neuroscience Institute, Scottsdale, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Macwan+S%22">Macwan S</searchLink>; Department of Neurology, Eisenhower Health, Rancho Mirage, CA, USA.<br /><searchLink fieldCode="AU" term="%22Shieh+PB%22">Shieh PB</searchLink>; Department of Neurology and Pediatrics, University of California Los Angeles, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Weiss+MD%22">Weiss MD</searchLink>; Department of Neurology, University of Washington Medical Center, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Bloemers+J%22">Bloemers J</searchLink>; UCB, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Boroojerdi+B%22">Boroojerdi B</searchLink>; UCB, Monheim, Germany.<br /><searchLink fieldCode="AU" term="%22Delicha+EM%22">Delicha EM</searchLink>; UCB, Braine-l'Alleud, Belgium.<br /><searchLink fieldCode="AU" term="%22Lavrov+A%22">Lavrov A</searchLink>; UCB, Monheim, Germany.<br /><searchLink fieldCode="AU" term="%22Singh+P%22">Singh P</searchLink>; UCB, Slough, UK.<br /><searchLink fieldCode="AU" term="%22Howard+JF+Jr%22">Howard JF Jr</searchLink>; Department of Neurology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101480242%22">Therapeutic advances in neurological disorders</searchLink> [Ther Adv Neurol Disord] 2025 Jul 05; Vol. 18, pp. 17562864251347283. <i>Date of Electronic Publication: </i>2025 Jul 05 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22SAGE%22">SAGE </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101480242 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1756-2856 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217562856%22">17562856 </searchLink><i>NLM ISO Abbreviation: </i>Ther Adv Neurol Disord <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40620733
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/17562864251347283
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 17562864251347283
    Titles:
      – TitleFull: Switching to subcutaneous zilucoplan from intravenous complement component 5 inhibitors in generalised myasthenia gravis: a phase IIIb, open-label study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Freimer M
      – PersonEntity:
          Name:
            NameFull: Desai U
      – PersonEntity:
          Name:
            NameFull: Govindarajan R
      – PersonEntity:
          Name:
            NameFull: Kang MK
      – PersonEntity:
          Name:
            NameFull: Khan S
      – PersonEntity:
          Name:
            NameFull: Khatri B
      – PersonEntity:
          Name:
            NameFull: Levine T
      – PersonEntity:
          Name:
            NameFull: Macwan S
      – PersonEntity:
          Name:
            NameFull: Shieh PB
      – PersonEntity:
          Name:
            NameFull: Weiss MD
      – PersonEntity:
          Name:
            NameFull: Bloemers J
      – PersonEntity:
          Name:
            NameFull: Boroojerdi B
      – PersonEntity:
          Name:
            NameFull: Delicha EM
      – PersonEntity:
          Name:
            NameFull: Lavrov A
      – PersonEntity:
          Name:
            NameFull: Singh P
      – PersonEntity:
          Name:
            NameFull: Howard JF Jr
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 05
              M: 07
              Text: 2025 Jul 05
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 1756-2856
          Numbering:
            – Type: volume
              Value: 18
          Titles:
            – TitleFull: Therapeutic advances in neurological disorders
              Type: main
ResultId 1